Document is current

Any future updates will be listed below

IAP antagonists Birinapant and AT-406 efficiently synergise with either TRAIL, BRAF, or BCL-2 inhibitors to sensitise BRAFV600E colorectal tumour cells to apoptosis

Crossref DOI link: https://doi.org/10.1186/s12885-016-2606-5

Published Online: 2016-08-12

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark